T(reg) cell-based therapies: challenges and perspectives
Consortia: CTAR
Raffin C, Vo LT, Bluestone JA.
Nat Rev Immunol. 2019 Dec 6. doi: 10.1038/s41577-019-0232-6. Review. PMID:31811270
Consortia: CTAR
Raffin C, Vo LT, Bluestone JA.
Nat Rev Immunol. 2019 Dec 6. doi: 10.1038/s41577-019-0232-6. Review. PMID:31811270